_version_ 1783717534544953344
author Lim, Sean H
Campbell, Nicola
Johnson, Marina
Joseph-Pietras, Debora
Collins, Graham P
O'Callaghan, Ann
Fox, Christopher P
Ahearne, Matthew
Johnson, Peter W M
Goldblatt, David
Davies, Andrew J
author_facet Lim, Sean H
Campbell, Nicola
Johnson, Marina
Joseph-Pietras, Debora
Collins, Graham P
O'Callaghan, Ann
Fox, Christopher P
Ahearne, Matthew
Johnson, Peter W M
Goldblatt, David
Davies, Andrew J
author_sort Lim, Sean H
collection PubMed
description
format Online
Article
Text
id pubmed-8253538
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-82535382021-07-06 Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma Lim, Sean H Campbell, Nicola Johnson, Marina Joseph-Pietras, Debora Collins, Graham P O'Callaghan, Ann Fox, Christopher P Ahearne, Matthew Johnson, Peter W M Goldblatt, David Davies, Andrew J Lancet Haematol Comment Elsevier Ltd. 2021-08 2021-07-02 /pmc/articles/PMC8253538/ /pubmed/34224667 http://dx.doi.org/10.1016/S2352-3026(21)00199-X Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Lim, Sean H
Campbell, Nicola
Johnson, Marina
Joseph-Pietras, Debora
Collins, Graham P
O'Callaghan, Ann
Fox, Christopher P
Ahearne, Matthew
Johnson, Peter W M
Goldblatt, David
Davies, Andrew J
Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
title Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
title_full Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
title_fullStr Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
title_full_unstemmed Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
title_short Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
title_sort antibody responses after sars-cov-2 vaccination in patients with lymphoma
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253538/
https://www.ncbi.nlm.nih.gov/pubmed/34224667
http://dx.doi.org/10.1016/S2352-3026(21)00199-X
work_keys_str_mv AT limseanh antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT campbellnicola antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT johnsonmarina antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT josephpietrasdebora antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT collinsgrahamp antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT ocallaghanann antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT foxchristopherp antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT ahearnematthew antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT johnsonpeterwm antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT goldblattdavid antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma
AT daviesandrewj antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma